AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8447035 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate powder
Number of subjects: 27
Study 8447035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 3722689 — intervention group
Group type: EXPERIMENTAL
Intervention: Different plastics for rigid contact lenses worn for four hours
Number of subjects: 0
Study 29313486 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (0.15 mg/kg)
Number of subjects: 49
Study 29313486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 27680871 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-observation (live video feedback of their own TPT performance)
Number of subjects: 48
Study 27680871 — intervention group
Group type: EXPERIMENTAL
Intervention: Model observation (prerecorded video showing standard TPT)
Number of subjects: 48
Study 27680871 — intervention group
Group type: COMPARATOR
Intervention: Control group (performed the TPT with no conditioning)
Number of subjects: 48
Study 24354686 — intervention group
Group type: EXPERIMENTAL
Intervention: Clip attachments (group I, GI)
Number of subjects: 30
Study 24354686 — intervention group
Group type: COMPARATOR
Intervention: Silicone resilient liners (group II, GII)
Number of subjects: 30
Study 22305412 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterless scrub
Number of subjects: 100
Study 22305412 — intervention group
Group type: COMPARATOR
Intervention: Traditional scrub
Number of subjects: 100
Study 21197713 — intervention group
Group type: EXPERIMENTAL
Intervention: Valganciclovir (900 mg) once daily for up to 200 days
Number of subjects: 318
Study 21197713 — intervention group
Group type: COMPARATOR
Intervention: Valganciclovir (900 mg) once daily for up to 100 days
Number of subjects: 318
Study 18438718 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI/ARB continuation group
Number of subjects: 220
Study 18438718 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI/ARB discontinuation group
Number of subjects: 220
Study 18438718 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin blockade naïve group
Number of subjects: 220
Study 14982549 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance abuse treatment
Number of subjects: 349
Study 14982549 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of antiretroviral medication
Number of subjects: 349
Study 14982549 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 349
Study 14982549 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of drugs or alcohol in the previous 30 days
Number of subjects: 349
Study 14982549 — intervention group
Group type: EXPERIMENTAL
Intervention: More depressive symptoms
Number of subjects: 349
Study 11314834 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg/kg
Number of subjects: 30
Study 11314834 — intervention group
Group type: COMPARATOR
Intervention: Pethidine 0.5 mg/kg
Number of subjects: 30
Study 9388088 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (3766 J [900 calories], 50 g of fat)
Number of subjects: 20
Study 9388088 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal (3766 J [900 calories], 0 g of fat)
Number of subjects: 20
Study 9388088 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal with vitamins C (1 g) and E (800 IU)
Number of subjects: 20
Study 9388088 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat meal with vitamins C (1 g) and E (800 IU)
Number of subjects: 20
Study 8201642 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phenobarbital plus ergotamine
Number of subjects: 68
Study 8201642 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 68
Study 8201642 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol
Number of subjects: 68
Study 8201642 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate
Number of subjects: 68
Study 3147423 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (local anaesthetic)
Number of subjects: 26
Study 3147423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 3147423 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine injections
Number of subjects: 26
Study 28038497 — intervention group
Group type: EXPERIMENTAL
Intervention: Picture book distraction intervention
Number of subjects: 276
Study 28038497 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated cartoon distraction intervention
Number of subjects: 276
Study 28038497 — intervention group
Group type: COMPARATOR
Intervention: Routine oral instructions (Control)
Number of subjects: 276
Study 26705931 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Dose Trivalent Inactivated Influenza Vaccine (60 μg HA/strain/dose)
Number of subjects: 44
Study 26705931 — intervention group
Group type: COMPARATOR
Intervention: Standard-Dose Trivalent Inactivated Influenza Vaccine (15 μg HA/strain/dose)
Number of subjects: 44
Study 27337802 — intervention group
Group type: EXPERIMENTAL
Intervention: PCUM (critical care ultrasonic examination)
Number of subjects: 187
Study 27337802 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 187
Study 23357349 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative PFMT (3 weeks before surgery and continued after surgery)
Number of subjects: 180
Study 23357349 — intervention group
Group type: COMPARATOR
Intervention: Postoperative PFMT (started after catheter removal)
Number of subjects: 180
Study 23357349 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative PFMT
Number of subjects: 180
Study 23357349 — intervention group
Group type: COMPARATOR
Intervention: Postoperative PFMT
Number of subjects: 180
Study 19515542 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipeptidyl Peptidase‐4 (DPP‐4) inhibitors
Number of subjects: 41
Study 19515542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 19515542 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP‐4 inhibitors
Number of subjects: 41
Study 18437480 — intervention group
Group type: EXPERIMENTAL
Intervention: Indigenous balloon dissection (group 1)
Number of subjects: 56
Study 18437480 — intervention group
Group type: COMPARATOR
Intervention: Direct telescopic dissection (group 2)
Number of subjects: 56
Study 17161067 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 126
Study 17161067 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 126
Study 12707819 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernioplasty
Number of subjects: 27
Study 12707819 — intervention group
Group type: COMPARATOR
Intervention: Conventional repair
Number of subjects: 27
Study 10645918 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab plus reduced-dose tPA (combination therapy)
Number of subjects: 346
Study 10645918 — intervention group
Group type: COMPARATOR
Intervention: tPA alone (control)
Number of subjects: 346
Study 8785148 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.05 mg kg‐1
Number of subjects: 40
Study 8785148 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 8785148 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngoscopy (after vecuronium and saline)
Number of subjects: 40
Study 1558994 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical alpha-interferon ointment with dimethyl sulfoxide
Number of subjects: 100
Study 1558994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 4052837 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual abuse prevention training program (3-hour duration)
Number of subjects: 0
Study 4052837 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 31187955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrox 99
Number of subjects: 10
Study 31187955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrox 50
Number of subjects: 10
Study 31187955 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 10
Study 28864073 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT) planned using pre-induction chemotherapy images (group A)
Number of subjects: 212
Study 28864073 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT) planned using post-induction chemotherapy images (group B)
Number of subjects: 212
Study 26967222 — intervention group
Group type: EXPERIMENTAL
Intervention: SR 23 mg/day donepezil
Number of subjects: 351
Study 26967222 — intervention group
Group type: COMPARATOR
Intervention: IR 10 mg/day donepezil
Number of subjects: 351
Study 24895339 — intervention group
Group type: EXPERIMENTAL
Intervention: RA-CHOP
Number of subjects: 787
Study 24895339 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 787
Study 22849758 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (300 mg at h.s. daily)
Number of subjects: 46
Study 22849758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 22849758 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone (during withdrawal study)
Number of subjects: 46
Study 22849758 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during withdrawal study)
Number of subjects: 46
Study 20833266 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT with a defibrillator (CRT-D)
Number of subjects: 1803
Study 20833266 — intervention group
Group type: COMPARATOR
Intervention: Defibrillator-only therapy
Number of subjects: 1803
Study 16815571 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training program (ETP) consisting of 24 training sessions with aerobic exercise and muscle strengthening
Number of subjects: 30
Study 16815571 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training program (ETP)
Number of subjects: 30
Study 16815571 — intervention group
Group type: COMPARATOR
Intervention: Control group (2-month control period)
Number of subjects: 30
Study 15179643 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Dysport) injections (200U each into medial and lateral heads of gastrocnemius and 400U each into tibialis posterior) and Functional Electric Stimulation (FES) used daily for 16 weeks
Number of subjects: 21
Study 15179643 — intervention group
Group type: COMPARATOR
Intervention: Control group (physiotherapy at the same rate)
Number of subjects: 21
Study 11453318 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine (50 mg bid)
Number of subjects: 48
Study 11453318 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (20 mg tid)
Number of subjects: 48
Study 11453318 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine (50 mg bid) and Medroxyprogesterone acetate (20 mg tid)
Number of subjects: 48
Study 9870483 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate solution (38 mmol/l of bicarbonate)
Number of subjects: 59
Study 9870483 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate/lactate solution (25 mmol/l bicarbonate and 15 mmol/l lactate)
Number of subjects: 59
Study 9870483 — intervention group
Group type: COMPARATOR
Intervention: Control solution (40 mmol/l lactate)
Number of subjects: 59
Study 7809441 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutter VRP1
Number of subjects: 0
Study 7809441 — intervention group
Group type: COMPARATOR
Intervention: Active cycle of breathing techniques
Number of subjects: 0
Study 2972785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2972785 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (100 micrograms/kg)
Number of subjects: 8
Study 2972785 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-endorphin (in vitro before exercise)
Number of subjects: 8
Study 2972785 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-endorphin (after exercise)
Number of subjects: 8
Study 29278818 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg three times daily
Number of subjects: 48
Study 29278818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 27235677 — intervention group
Group type: EXPERIMENTAL
Intervention: 20‐mL 1% buffered lidocaine four‐site PCB with a 3‐min wait prior to cervical dilation
Number of subjects: 332
Study 27235677 — intervention group
Group type: COMPARATOR
Intervention: 20‐mL 1% buffered lidocaine four‐site PCB with no wait prior to cervical dilation
Number of subjects: 332
Study 27235677 — intervention group
Group type: EXPERIMENTAL
Intervention: 20‐mL 1% buffered lidocaine four‐site PCB (four‐site)
Number of subjects: 332
Study 27235677 — intervention group
Group type: COMPARATOR
Intervention: 20‐mL 1% buffered lidocaine two‐site PCB
Number of subjects: 332
Study 25626066 — intervention group
Group type: EXPERIMENTAL
Intervention: Patent blue dye (BD) combined with preoperative lymphoscintigraphy (LSG) and gamma probe (GP)
Number of subjects: 1088
Study 25626066 — intervention group
Group type: COMPARATOR
Intervention: Patent blue dye (BD) alone
Number of subjects: 1088
Study 23289648 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 month pedometer and accelerometer based intervention supported by practice nurse physical activity consultations.
Number of subjects: 300
Study 20537805 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 0
Study 20537805 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 18356335 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium iron EDTA (NaFeEDTA) at 10 mg/kg flour
Number of subjects: 361
Study 18356335 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous fumarate at 20 mg/kg flour
Number of subjects: 361
Study 18356335 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolytic iron at 35 mg/kg flour
Number of subjects: 361
Study 18356335 — intervention group
Group type: COMPARATOR
Intervention: No fortification iron (Control)
Number of subjects: 361
Study 17046465 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 312
Study 17046465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 14725229 — intervention group
Group type: EXPERIMENTAL
Intervention: Milligan‐Morgan haemorrhoidectomy plus chemical sphincterotomy (Group A)
Number of subjects: 60
Study 14725229 — intervention group
Group type: EXPERIMENTAL
Intervention: Milligan‐Morgan haemorrhoidectomy plus internal left lateral sphincterotomy (0.8‐1 cm) (Group B)
Number of subjects: 60
Study 14725229 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan haemorrhoidectomy alone (Group C)
Number of subjects: 60
Study 15794071 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine (60 mg)
Number of subjects: 238
Study 15794071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 10510524 — intervention group
Group type: EXPERIMENTAL
Intervention: Glove method
Number of subjects: 8
Study 10510524 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwash method
Number of subjects: 8
Study 10510524 — intervention group
Group type: EXPERIMENTAL
Intervention: Wipe method
Number of subjects: 8
Study 7614644 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (20 micrograms.kg‐1)
Number of subjects: 88
Study 7614644 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 88
Study 7614644 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron plus Dexamethasone (20 micrograms.kg‐1 and 8 mg)
Number of subjects: 88
Study 7614644 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 88
Study 2037957 — intervention group
Group type: EXPERIMENTAL
Intervention: Decalcified freeze-dried bone allograft (DFDBA) combined with an expanded polytetrafluoroethylene membrane (e-PTFE)
Number of subjects: 30
Study 2037957 — intervention group
Group type: COMPARATOR
Intervention: Barrier technique alone (e-PTFE membrane)
Number of subjects: 30
Study 7211827 — intervention group
Group type: EXPERIMENTAL
Intervention: Handwashing program (HWC)
Number of subjects: 0
Study 7211827 — intervention group
Group type: COMPARATOR
Intervention: Control centers (CC)
Number of subjects: 0
Study 27792852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rest and graduated return to usual activity discharge instructions
Number of subjects: 118
Study 27792852 — intervention group
Group type: COMPARATOR
Intervention: Usual care discharge instructions (control group)
Number of subjects: 118
Study 25026508 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing retraining plus manual therapy (MT), n=30
Number of subjects: 60
Study 25026508 — intervention group
Group type: COMPARATOR
Intervention: Breathing retraining (standard treatment), n=30
Number of subjects: 60
Study 23625093 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation of the pulmonary veins (CAPV)
Number of subjects: 63
Study 22060249 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 57
Study 22060249 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction training
Number of subjects: 57
Study 22060249 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 57
Study 19088467 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epoetin
Number of subjects: 157
Study 19088467 — intervention group
Group type: COMPARATOR
Intervention: Intravenous epoetin
Number of subjects: 157
Study 17570848 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (Arsucam)
Number of subjects: 0
Study 17570848 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus mefloquine (Artequin)
Number of subjects: 0
Study 17570848 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether plus lumefantrine (Coartem; four doses)
Number of subjects: 0
Study 17570848 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether plus lumefantrine (Coartem; six doses)
Number of subjects: 0
Study 17570848 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulphadoxine‐pyrimethamine
Number of subjects: 0
Study 17570848 — intervention group
Group type: EXPERIMENTAL
Intervention: All combinations
Number of subjects: 0
Study 15126812 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfuzosin 10 mg once daily
Number of subjects: 360
Study 15126812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study 11820045 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide gel with 3% potassium nitrate and 0.11 fluoride ion
Number of subjects: 21
Study 11820045 — intervention group
Group type: COMPARATOR
Intervention: 10% carbamide peroxide gel only (control)
Number of subjects: 21
Study 9924466 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU oral nHuIFN-alpha/day
Number of subjects: 559
Study 9924466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 559
Study 7816333 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg)
Number of subjects: 8
Study 7816333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3041248 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone treatment (oestrogen and norethisterone acetate)
Number of subjects: 49
Study 3041248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 31142348 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed fecal test and stepped phone-outreach intervention program (Hybrid 1)
Number of subjects: 57673
Study 31142348 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed fecal immunochemical test (FIT) outreach (Hybrid 2)
Number of subjects: 57673
Study 31142348 — intervention group
Group type: EXPERIMENTAL
Intervention: Two strategies for implementing mailed FIT programs (Hybrid 3)
Number of subjects: 57673
Study 28327566 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholegrain rye (WGR)
Number of subjects: 70
Study 28327566 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat (RW)
Number of subjects: 70
Study 28327566 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholegrain wheat (WGW)
Number of subjects: 70
Study 26275453 — intervention group
Group type: EXPERIMENTAL
Intervention: Plumpy'doz
Number of subjects: 5536
Study 26275453 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice-lentil based food
Number of subjects: 5536
Study 26275453 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpea based food
Number of subjects: 5536
Study 26275453 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified blended food (WSB++)
Number of subjects: 5536
Study 26275453 — intervention group
Group type: COMPARATOR
Intervention: Nutrition counselling alone
Number of subjects: 5536
Study 23652778 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (20 mg intravenous injection)
Number of subjects: 859
Study 23652778 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 859
Study 21829522 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0
Study 21829522 — intervention group
Group type: COMPARATOR
Intervention: Cathodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0
Study 19074543 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 33
Study 17627814 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral DHEA (50mg capsules, 2 capsules daily for 14 days)
Number of subjects: 36
Study 17627814 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous DHEA (4g of 10% DHEA cream or gel daily for 14 days)
Number of subjects: 36
Study 17627814 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 36
Study 15303137 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative autotransfusion (IAT) using ZITI‐3000 Cell saving system
Number of subjects: 20
Study 15303137 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intraoperative autotransfusion)
Number of subjects: 20
Study 11748599 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR) treatment
Number of subjects: 32
Study 11748599 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 32
Study 9449495 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol beclomethasone dipropionate spray (84 microg four times per day)
Number of subjects: 747